Colchicine Coronavirus SARS-CoV2 Trial
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Colchicine Coronavirus SARS-CoV2 Trial is a clinical trial[1].
Key Facts
- Colchicine Coronavirus SARS-CoV2 Trial is in the country of Canada[2].
- Colchicine Coronavirus SARS-CoV2 Trial's instance of is recorded as clinical trial[3].
- Colchicine Coronavirus SARS-CoV2 Trial's start time is recorded as +2020-03-23T00:00:00Z[4].
- Colchicine Coronavirus SARS-CoV2 Trial's end time is recorded as +2020-09-30T00:00:00Z[5].
- Colchicine Coronavirus SARS-CoV2 Trial's official website is recorded as https://www.colcorona.net/[6].
- Colchicine Coronavirus SARS-CoV2 Trial's sponsor is recorded as Montreal Heart Institute[7].
- Colchicine Coronavirus SARS-CoV2 Trial's sponsor is recorded as Government of Quebec[8].
- Colchicine Coronavirus SARS-CoV2 Trial's sponsor is recorded as CGI Group[9].
- Colchicine Coronavirus SARS-CoV2 Trial's sponsor is recorded as Sophie Desmarais[10].
- Colchicine Coronavirus SARS-CoV2 Trial's main subject is recorded as cytokine release syndrome[11].
- Colchicine Coronavirus SARS-CoV2 Trial's main subject is recorded as SARS-CoV-2[12].
- Colchicine Coronavirus SARS-CoV2 Trial's main subject is recorded as severe acute respiratory syndrome[13].
- Colchicine Coronavirus SARS-CoV2 Trial's number of participants is recorded as {'unit': '1', 'amount': '+6000'}[14].
- Colchicine Coronavirus SARS-CoV2 Trial's title is recorded as Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)[15].
- Colchicine Coronavirus SARS-CoV2 Trial's short name is recorded as COLCORONA[16].
- Colchicine Coronavirus SARS-CoV2 Trial's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+40'}[17].
- Colchicine Coronavirus SARS-CoV2 Trial's ClinicalTrials.gov ID is recorded as NCT04322682[18].
- Colchicine Coronavirus SARS-CoV2 Trial's research intervention is recorded as (S)-(−)-colchicine[19].
- Colchicine Coronavirus SARS-CoV2 Trial's clinical trial phase is recorded as phase III clinical trial[20].
- Colchicine Coronavirus SARS-CoV2 Trial's study type is recorded as interventional study[21].